Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Febrile Neutropenia 9Neoplasms 6Anemia, Refractory, with Excess of Blasts 5Venous Thromboembolism 4Leukemia, Myeloid, Acute 4Hematologic Neoplasms 4Anemia 4Thrombocytopenia 3Fanconi Anemia 2Congenital Bone Marrow Failure Syndromes 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Anemia, Iron-Deficiency 2Uterine Cervical Neoplasms 1Thrombophilia 1Stomatitis 1Stomach Neoplasms 1Shock, Septic 1Sepsis 1Scleroderma, Systemic 1Sarcoma 1Recurrence 1Radiation Injuries 1Pulmonary Embolism 1Pulmonary Blastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Periodontitis 1Neutropenia 1Neoplasms, Plasma Cell 1Myositis 1

Interventions

hetrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cancer Therapy-induced Thrombocytopenia (CTIT) × Classical hematology × Clear all
NCT07334093 2026-01-12

A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Sun Yat-sen University

Phase 2 Not yet recruiting
204 enrolled
Classical hematology

Cancer Therapy-induced Thrombocytopenia (CTIT)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡